Now I have read the paper thoroughly. Let me do calibration searches.Round 1 bracket: This paper sits in the protein representation learning space with structure-based encoders. Looking at the anchors, similar papers like ProteinINR (5.75, accept), ProteinWorkshop (6.25, accept), ProteiNexus (3.67, reject), and ProteinAdapter (3.40, reject) suggest a bracket between 4-6. Let me read 2 of these to position.Round 2 narrowing: Bracketing the paper between roughly 4 and 6. Let me search for more anchors in this range with specific topical relevance.## Summary
ProteinVista is a 123M-parameter full-atom 3D CNN that voxelizes heavy atoms at 1 Å resolution and is pre-trained on ~500K AlphaFold-2 structures via InfoNCE contrastive alignment to ESM-2 embeddings. The paper reports that on three protein–small molecule benchmarks (TSP, ESP, IC50 regression) ProteinVista is competitive with or beats ESM-2 at far lower compute (20s vs 426s per 1k proteins on A100), and that ensembling with ESM-2 yields complementary gains; an "optimized pipeline" (OP) variant beats current SOTA on TSP and ESP.

## Strengths
- **Clear empirical win on IC50 regression with a credible compute story.** ProteinVista alone reaches R² = 0.69 vs ESM-2_650M's 0.61 on BindingDB (Table 2), with a one-sided Wilcoxon p < 10⁻³⁰⁴, while requiring ~1% of the pre-training GPU-hours and ~20× faster inference than ESM-2_650M (Section 4.3, Figure 3). This is concrete evidence against the prevailing belief that whole-protein 3D CNNs are computationally infeasible.
- **Honest reporting of mixed results.** Section 3.4 directly acknowledges underperformance on Gene Ontology MF prediction (F_max 0.57 vs 0.62 for ESM-2_650M), and the discussion of when structure helps vs. when sequence/homology suffices is intellectually honest.
- **Useful stratification analysis.** Section 4.1 and Figure 2a–d partition the TSP test set by sequence identity, TM-score, and pLDDT, providing a nuanced characterization of when structure encoding adds value rather than relying solely on aggregate metrics.
- **Concrete ablations grounded in the IC50 metric.** Section 4.2 / Figure 2e quantifies the contribution of inference-time view averaging (−6.4% for 1 view vs 5), voxel resolution (−1.1% at 1.5 Å), and pretraining objective (CL vs Rosetta: −1.0%).

## Weaknesses

### Fatal
None.

### Major
- **The "outperforms sequence transformers on three benchmarks" framing is not what Table 1 supports for ESP.** On ESP, ProteinVista's standalone numbers (91.8% / 0.951 / 0.78 MCC) are essentially tied with or slightly behind ESM-2_650M (91.9% / 0.955 / 0.79 MCC); the only metric ProteinVista wins is precision (0.89 vs 0.86). Combined with the GO loss in Section 3.4, the empirical pattern is one clear win (IC50), one modest win (TSP), one wash (ESP), one loss (GO) — not a uniform sweep. The abstract, title, and §3.2 should be rewritten to match the actual evidence; the sharper "competitive at far lower compute, decisively wins on pocket-chemistry-heavy tasks" thesis is well-supported and would be more credible.
- **The OP-vs-SOTA comparison conflates pipeline engineering with architectural contribution.** §3.3 layers three additional tricks onto ESM-ProteinVista_OP (joint MolFormer fine-tuning, an additional contrastive network on fine-tuned embeddings, ensembling with ESM-2_650M) and then compares against SOTA baselines (SPOT, ProSmith-ESP, Fusion_ESP) reported in their original settings. Without an "ESM-2_650M with the same OP recipe" row, the gap between ESM-ProteinVista_OP and SOTA cannot be attributed to the ProteinVista encoder rather than to the ensemble + contrastive-network engineering.
- **The contrastive pretraining objective sits in tension with the complementarity narrative.** §2.3 distills ESM-2 information into the structure encoder via InfoNCE on a shared projection space, yet §3.2/Figure 2 then argues ProteinVista carries information *complementary* to ESM-2 and demonstrates this via ensemble gains. The 1% R² gap from the CL-vs-Rosetta ablation (§4.2) is too small to establish whether the residual complementarity comes from the 3D inductive bias, the fine-tuning signal, or something else. A no-pretrain baseline and a Rosetta-only baseline (already partially run) would together disentangle (a) the voxel inductive bias, (b) the CL alignment, and (c) large-scale 3D pretraining.

### Minor
- **Single-seed reporting on the core comparisons.** McNemar/Wilcoxon tests on the test set are reported, but no across-seed variance is shown. With sub-0.5-point gaps to ESM-2_650M on ESP, the absence of seed variance leaves real ambiguity about whether the close margins are within noise.
- **The rotation-invariance story is undercut by §4.2.** The augmentation set is the cubic symmetry group (identity + 3 mirrors + 90°-axis rotations), not uniform SO(3). The ablation shows that disabling training-time augmentation has −0.1% effect while disabling test-time multi-view averaging costs 5.5–6.4%. The model is therefore not truly rotation-invariant; it depends on test-time view averaging. The paper should state this plainly rather than describe the model as "rotation-invariant."
- **Cropping at 160³ Å³ is unanalyzed.** §2.1 mentions that structures exceeding the largest box are cropped at the bounding box, but the paper does not report what fraction of train/test proteins are cropped or whether cropping excises binding sites — directly relevant since these are pocket-recognition tasks.
- **Ensemble-worse-than-single on IC50 is explained post-hoc.** §3.2 attributes ESM-ProteinVista < ProteinVista on IC50 to sequence having nothing to add when affinity depends on fine geometry. A clean control — averaging two ProteinVista runs — would rule out the simpler "averaging dilutes a strong model with a weaker one" effect.

### Trivial
- The OP recipe in §3.3 is too compressed: the architecture of the contrastive networks, weighting of the three ensemble components, and whether MolFormer was updated per-task are not specified.

## Nice-to-Haves
- A small SE(3)-equivariant baseline (e.g., a Tensor Field Network or SE(3)-Transformer) on TSP or IC50 would clarify whether the augmentation + multi-view-averaging recipe is competitive with proper equivariance or merely cheaper.
- Task-difficulty stratification by how much each task depends on pocket-level chemistry (affinity regression vs coarse classification) would sharpen the "when does structure help" thesis already gestured at in §3.4.
- A breakdown of where ProteinVista does better/worse on GO terms (binding-related MF vs catalytic) would make the structure-vs-homology argument concrete.
- Grad-CAM–style attribution on 3D voxels (already mentioned in the discussion as future work) would convert the "the model finds binding pockets" claim into evidence.

## Removed Points
*These points are flagged to be removed; treat them with caution.*

- **"Compute comparison conflates parallelism with architecture"** — The paper itself acknowledges that FLOPs are similar (415 vs 520 GFLOPs) but wall-clock differs due to parallelism, and discusses this transparently in §4.3. The reviewer's criticism is a reasonable nice-to-have but the paper does not overclaim here.
- **"Stratified results raise memorization-vs-generalization question that is not engaged"** — The paper does engage with this directly via the pLDDT and TM-score stratifications (§4.1, Fig. 2b–c) and provides a balanced view. The competing interpretation is acknowledged in spirit; demoting to nice-to-have.
- **"Receptive field analysis missing"** — Architectural detail that would strengthen but is not a flaw given the empirical demonstration.
- **"Voxel grids could be stored more compactly"** — A reasonable engineering suggestion, not a weakness in the paper's claims; the paper transparently reports the storage trade-off.
- **Strength: "open-source Python implementation"** — Generic; not a substantive technical strength on its own.
- **Strength: "addresses an important problem"** — Generic framing; removed per filtering rules.

## Novel Insights
None beyond the paper's own contributions. The paper's own observation — that 3D CNNs are competitive at the orders-of-magnitude lower compute budget and decisively help on pocket-geometry tasks like affinity regression while adding little on homology-driven tasks like GO MF — is itself the most interesting takeaway. The current framing buries this in a stronger universal claim that does not survive Table 1.

## Suggestions
- Rewrite the abstract, title, and §3.2 to match the actual pattern of results: clear IC50 win, modest TSP win, ESP tie, GO loss. The sharper claim ("competitive at much lower compute; decisively wins on tasks dominated by pocket chemistry") is well-supported and more publishable than the universal claim.
- Add an "ESM-2_650M + OP" row to Table 1 so the architectural contribution of ProteinVista is isolated from the OP machinery.
- Add seed variance (≥3 seeds) on the main tables, especially ESP where margins are within 0.5 points.
- Add ablation rows for no-pretraining and Rosetta-only across multiple downstream tasks (not only IC50) to disentangle voxel inductive bias from CL distillation.
- Report what fraction of train/test proteins are cropped at the 160³ box and whether cropping affects ESP/TSP performance.
- Clarify that the model relies on test-time view averaging for rotation robustness rather than being intrinsically rotation-invariant, in light of the §4.2 ablation.
- Provide a two-ProteinVista-runs ensemble baseline to clarify the IC50 ensemble degradation.

## Evaluation Axes

- **Originality**: Moderate. Full-atom 3D voxel CNNs for proteins have prior history (DeepSite, EnzyNet, 3DCNN_MQA, cited in §1), but the combination of large-scale AlphaFold-2 pretraining, CL distillation from ESM-2, and a credible whole-protein pipeline is novel and timely.
- **Importance of question**: High. The "is 3D structure useful given strong PLMs?" question is central to current protein representation work.
- **Claim support**: Uneven. IC50 result is clearly supported; ESP and the "outperforms three benchmarks" headline are not.
- **Soundness of experiments**: Mostly solid (real test sets, statistical tests on differences), but single-seed and the apples-to-not-apples OP comparison weaken it.
- **Clarity**: Generally clear; the workflow, dataset, and ablations are easy to follow. Framing overclaims, however.
- **Value to community**: Real — a compute-efficient open-source structure encoder with documented strengths/weaknesses is useful.

## Anchors Considered

Round 1 anchors:
- `vVlNBaiLdN.md` (ESMGain, 3.00, reject) — protein mutation ESM2 transfer; topically adjacent but less ambitious than ProteinVista. ProteinVista is stronger.
- `jqx5XI4Yr3.md` (ProteinAdapter, 3.40, reject) — adapter-based reuse of LPMs; less original than ProteinVista.
- `rEQ8OiBxbZ.md` (LEGO, 3.00, reject) — 3D molecular pretraining; weaker scope than ProteinVista.
- `yIRtu2FJvY.md` (matVAE, 3.00, reject) — VAE for variant effect; less general.
- `iBAWiEjogY.md` (ProteiNexus, 3.67, reject) — structural pretraining for many tasks but had data-leakage and clarity concerns. ProteinVista is more transparent.
- `sTYuRVrdK3.md` (ProteinWorkshop, 6.25, accept) — comprehensive benchmark with thorough comparisons. ProteinVista is narrower but more methodologically focused.
- `BEH4mGo7zP.md` (ProteinINR, 5.75, accept) — surface+structure+sequence pretraining; multi-modal pretraining with marginal gains. ProteinVista is comparable in caliber but with framing concerns that ProteinINR lacks.
- `OzUNDnpQyd.md` (Structure LM, 7.00, accept) — methodologically stronger generative formulation.
- `0ctvBgKFgc.md`, `zMPHKOmQNb.md`, `kJFIH23hXb.md`, `gHLWTzKiZV.md` (all 8.00, accept) — substantially stronger generative-model contributions; ProteinVista is clearly below this tier.

Round 1 bracket: 4–6.

Round 2 anchors:
- `760br3YEtY.md` (PEEP, 5.60, reject) — enzyme promiscuity prediction; similar problem domain. ProteinVista has a stronger compute-efficiency angle but similar framing problems → comparable.
- `T7lQGq73Lm.md` (RetrEZyme, 5.50, reject) — enzyme generation; less directly comparable.
- `jsQPjIaNNh.md` (Inter-Protein Similarity, 5.25, reject) — function-prediction retriever; similar caliber.
- `0sU4myabw1.md` (RapidDock, 4.25, reject) — fast docking; below ProteinVista.
- `6ktqrC1Bpf.md` (bio2token, 5.00, reject) — all-atom tokenization with concrete results; similar caliber.
- `SjgfWbamtN.md` (MiniFold, 4.25, reject) — efficient structure prediction; weaker than ProteinVista.
- `t0m0DdCCQ2.md` (Liteformer, 4.33, reject) — efficient Evoformer; weaker scope.
- `5z9GjHgerY.md` (DPLM-2, 6.33, accept) — multimodal diffusion PLM; methodologically more ambitious than ProteinVista.
- `bM6LUC2lec.md` (Seqs2Seqs MSA, 5.67, reject) — generative MSA; comparable caliber.

Round 2 narrowed bracket: 4.5–5.5. ProteinVista is comparable in caliber to PEEP (5.60), bio2token (5.00), and Inter-Protein Similarity (5.25) — all borderline-reject papers with real contributions but a notable framing or evaluation gap. It is slightly weaker than ProteinINR (5.75, accept) because of the universal "outperforms" overclaim and the non-apples-to-apples OP comparison, and stronger than ProteiNexus (3.67) and ProteinAdapter (3.40) on transparency and concrete results.

Final score: 5.0 — a borderline-reject in line with PEEP / bio2token: a real, useful empirical contribution undermined by framing overclaim, missing ESM-2_OP control, and single-seed reporting that the rebuttal could plausibly address.

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>